The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 26, 2011
Filed:
Mar. 12, 2010
Kevin D. Mccormick, Basking Ridge, NJ (US);
Christopher W. Boyce, Flemington, NJ (US);
Neng-yang Shih, Lexington, MA (US);
Robert G. Aslanian, Rockaway, NJ (US);
Pietro Mangiaracina, Monsey, NY (US);
Manuel DE Lera Ruiz, Branchburg, NJ (US);
Younong Yu, East Brunswick, NJ (US);
Purakkattle Biju, Piscataway, NJ (US);
Chia-yu Huang, West Windsor, NJ (US);
BO Liang, Lawrenceville, NJ (US);
Ruiyan Liu, Yardley, PA (US);
Rong-qiang Liu, Kendall Park, NJ (US);
Lisa Guise-zawacki, Yardley, PA (US);
Kevin D. McCormick, Basking Ridge, NJ (US);
Christopher W. Boyce, Flemington, NJ (US);
Neng-Yang Shih, Lexington, MA (US);
Robert G. Aslanian, Rockaway, NJ (US);
Pietro Mangiaracina, Monsey, NY (US);
Manuel de Lera Ruiz, Branchburg, NJ (US);
Younong Yu, East Brunswick, NJ (US);
Purakkattle Biju, Piscataway, NJ (US);
Chia-Yu Huang, West Windsor, NJ (US);
Bo Liang, Lawrenceville, NJ (US);
Ruiyan Liu, Yardley, PA (US);
Rong-Qiang Liu, Kendall Park, NJ (US);
Lisa Guise-Zawacki, Yardley, PA (US);
Pharmacopeia Drug Discovery, Inc., Princeton, NJ (US);
Scheeing Corporation, Kenilworth, NJ (US);
Abstract
In its many embodiments, the present invention relates to a novel class of phenylmorpholine and phenylthiomorpholine compounds useful as α2C adrenergic receptor agonists, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the α2C adrenergic receptor agonists using such compounds or pharmaceutical compositions.